Investor Relations

LIFNano™ holds a robust intellectual property position


LIFNano Therapeutics Intellectual Property portfolio comprises five patent families covering formulations and methods of use for LIF nanoparticles. The Company's filing strategy has preserved substantial scope for further broadening of method claims to encompass other therapeutic uses and extend patent life.

Our Freedom to Operate includes world-wide exclusive license to the two LIFNano patents: one covering immune-linked indications; the second neurodegenerative diseases.

Should you be interested in discussing potential investment opportunities, we would of course be delighted to hear from you. Please contact us by email in the first instance.